Molecules, Vol. 25, Pages 1615: Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents

Molecules, Vol. 25, Pages 1615: Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents Molecules doi: 10.3390/molecules25071615 Authors: Jyothi Dhuguru Rachid Skouta Lung cancer is the leading cause of death in men and women worldwide, affecting millions of people. Between the two types of lung cancers, non-small cell lung cancer (NSCLC) is more common than small cell lung cancer (SCLC). Besides surgery and radiotherapy, chemotherapy is the most important method of treatment for lung cancer. Indole scaffold is considered one of the most privileged scaffolds in heterocyclic chemistry. Indole may serve as an effective probe for the development of new drug candidates against challenging diseases, including lung cancer. In this review, we will focus on discussing the existing indole based pharmacophores in the clinical and pre-clinical stages of development against lung cancer, along with the synthesis of some of the selected anti-lung cancer drugs. Moreover, the basic mechanism of action underlying indole based anti-lung cancer treatment, such as protein kinase inhibition, histone deacetylase inhibition, DNA topoisomerase inhibition, and tubulin inhibition will also be discussed.
Source: Molecules - Category: Chemistry Authors: Tags: Review Source Type: research